New insights into Goodpasture\u27s syndrome by Nagami, Glenn Tetsu
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1978
New insights into Goodpasture's syndrome
Glenn Tetsu Nagami
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation




Permission for photocopying or microfilming of "New Insights into 
Goodpasture's Syndrome" for the purpose of individual scholarly consultation 
or reference is hereby granted by the author. This permission is not to 
be interpreted as affecting publication of this work or otherwise placing 
it in the public domain, and the author reserves all rights of ownership 
guaranteed under common law protection of unpublished manuscripts. 
Date 
Digitized by the Internet Archive 
in 2017 with funding from 




NEW INSIGHTS INTO GOODPASTURE'S SYNDROME 
by 
Glenn Tetsu Nagami 
B.A. Pomona College 1973 
A Thesis Presented to 
The Faculty of the School of Medicine 
Yale University 
In Partial Fulfillment of the Requirements for 





To my parents 

ABSTRACT 
One hundred sixty-three cases of Goodpasture's syndrome from the 
English literature and our files were reviewed in order to gain insight 
into the clinical and laboratory characteristics of this condition and the 
efficacy of various modes of treatment used in this syndrome. Fifty-three 
cases met the criteria for a definite diagnosis of Goodpasture's syndrome: 
1) pulmonary hemorrhage; 2) glomerulonephritis; and 3) evidence of anti- 
glomerular basement membrane (anti-GBM) antibody formation. One hundred 
ten fulfilled the first two criteria but did not have immunologic studies 
documenting the presence of anti-GBM antibodies; these cases were considered 
to have a presumptive diagnosis of Goodpasture's syndrome. 
The clinical features of patients with the definite diagnosis of Good¬ 
pasture's syndrome were similar to those of patients with the presumptive 
diagnosis. Young males were most frequently afflicted. Pulmonary symptoms 
such as hemoptysis, cough and dyspnea were prominent presenting features. 
Renal symptoms such as gross hematuria, edema, and flank pain occurred less 
frequently. Common abnormal laboratory findings included infiltrates on 
chest X-ray examination, anemia, hematuria, and proteinuria. 
Renal function at initial hospitalization and renal biopsy specimen 
morphology may serve as prognostic indicators. Diminished renal function and 
diffuse glomerular involvement frequently presaged the onset of chronic 
renal failure and death. Diffuse glomerular involvement also appeared to 
be associated with death from fatal pulmonary hemorrhage. 
Maintenance dialysis appeared to be an important factor for the improved 
outlook of patients with Goodpasture's syndrome. Plasmapheresis, nephrectomy. 

and immunosuppressive agents seemed to have improved survival, 
a controlled study comparing the various therapeutic modalities 
to evaluate accurately the relative efficacy of each 
Nevertheless, 
is needed 
form of therapy. 
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Stanton and Tange (1) were the first to apply the eponym, Goodpasture's 
syndrome, to cases of pulmonary hemorrhage associated with glomerulonephritis. 
Because the pathogenic role of anti-glomerular basement membrane (anti-GBM) 
antibodies was not known at that time, their definition was purely clinical 
and, consequently, included a variety of disease entities such as uremia 
with congestive heart failure, glomerulonephritis with bacterial pneumonia, 
renal vein thrombosis with pulmonary embolism, Wegener's granulomatosis, 
polyarteritis nodosa, and systemic lupus erythematosis. Until the discovery 
of the importance of anti-glomerular basement membrane (anti-GBM) antibodies 
in the pathogenesis of the nephritis and lung hemorrhage (2, 3), the 
diagnosis of Goodpasture's syndrome could be made only after excluding the 
presence of clearly distinguishable conditions which could produce pulmonary 
hemorrhage and nephritis (4, 5). The current definition of Goodpasture's 
syndrome includes the triad of: 1) pulmonary hemorrhage; 2) glomerulonephri¬ 
tis; and 3) evidence of anti-GBM antibody formation (6, 7). This definition 
of Goodpasture's syndrome excludes those conditions in which pulmonary 
hemorrhage and glomerulonephritis may co-exist but anti-GBM antibody rarely, 
if ever, occurs. With this more precise definition it is possible to attempt 
to define more clearly the clinical spectrum of this disease. The purpose of 
the present study is to summarize our own experience and to review those 
cases reported in the literature of Goodpasture's syndrome. Special attention 
was directed toward the major clinical and laboratory features of the syndrome 
and to an analysis of the therapeutic modalities employed in this condition. 
- 1 - 
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METHODS 
The clinical records of all patients fulfilling the criteria of 
Goodpasture's syndrome at the Yale-New Haven Hospital during the years 1964 
to 1977 were reviewed. Case reports of Goodpasture's syndrome in the English 
literature were collected from Index Medicus and other papers cited in these 
reports up through August of 1977. All available information from each case 
report was abstracted. In many of the cases some of the data base v/as not 
presented and all percentages reported in the present paper are based on 
only those cases in whom information was available. Summaries of our five 
cases appear in the "Appendix". 
The diagnosis of definite Goodpasture's syndrome was accepted if the 
following criteria were met: (1) hemoptysis or lung tissue showing pulmonary 
hemorrhage; (2) clinical or laboratory evidence of renal disease with kidney 
tissue demonstrating glomerular involvement; and (3) demonstration of anti- 
GBM antibody by a) linear staining of the glomerular basement membrane with 
fluorescent-labelled antibodies against human immunoglobulin, b) detection of 
circulating anti-GBM antibodies in the patient's serum, or c) elution of anti- 
GBM antibodies from lung and/or kidney tissue. Patients who fulfilled the 
first two criteria and who did not have immunologic studies documenting the 
presence of anti-GBM antibodies were considered to have a presumptive 
diagnosis of Goodpasture's syndrome if the clinical picture and pathologic 
specimens were sufficient to exclude the presence of renal vein thrombosis 
with pulmonary embolism, uremia with congestive heart failure, Wegener's 
granulomatosis, systemic lupus erythematosis, and polyarteritis nodosa. 
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RESULTS 
Fifty cases with a definite diagnosis of Goodpasture's syndrome were 
discovered in the English literature (2, 8-39) and our files yielded another 
three cases for a total of 53 patients. All fifty-three had positive linear 
antibody staining of the glomerular basement membrane demonstrated by direct 
immunofluorescent studies. Twenty-four of twenty-seven in whom it was 
measured had detectable circulating anti-G8M antibodies. One hundred eight 
patients from the literature (1, 40-94) met the criteria for a presumptive 
diagnosis of Goodpasture's syndrome as did two patients from our files. All 
together 163 patients form the basis of this report. 
Demography. Thirty-eight of the fifty-three subjects with definte 
Goodpasture's syndrome were male yielding a male to female ratio of 2.5:1. 
Ninety of the 110 subjects with the presumptive diagnosis of Goodpasture’s 
syndrome were male. The ages of subjects with definite Goodpasture's 
syndrome ranged from 17 to 65 years with a median age of 23 years (Table I). 
Seventy percent of the patients were less than 30 years of age at the time 
of presentation. The decade of most frequent occurrence was the third. The 
age distribution in subjects with the presumptive diagnosis of Goodpasture's 
syndrome was similar to those with the definite diagnosis (Table I). 
Twenty-nine patients (55%) with the definite syndrome were white, one was 
an Eskimo, and twenty-three patients (43%) were of unspecified race. Fifty- 
two patients (47%) with the presumptive condition were white, five (5%) were 
black, one was a Native American, one was of Chinese-Polynesian extraction, 
and fifty-one (46%) were of unspecified race. 




Definite Diagnosis Presumptive Diagncsi 
Male 38 (72%) 90 (8255) 
SEX Female 15 (28%) 20 ( 1855) 
Male:Female 2 . 5:1.0 4. 5:1.0 
Less than 20 14 (26?5) 29 (2655) 
AGE 
20 to 30 23 (4355) 56 (5155) 
Greater than 30 16 (3155) 25 (24^5) 
Median age 24 22 
White 29 ( 5555) 52 (4755) 
RACE Black 0 ( 055) 5 ( 555) 
Other 1 ( 255) 2 ( 255) 






Symptoms at time of initial presentation (Table II). Forty-three out 
of fifty (86%) of the patients with a definite diagnosis of Goodpasture's 
syndrome had pulmonary symptoms at the time of presentation. Thirty-nine 
patients (73%) had hemoptysis, twenty-three (46%) had dyspnea, and fifteen 
(30%) had cough, and four (8%) had chest pain. Pulmonary symptoms occurring 
iri the absence of symptoms directly attributable to the urinary system 
(such as gross hematuria, flank pain, etc.) were reported in thirty-seven 
patients at the time of onset. 
Renal-related symptoms (gross hematuria, edema, and flank pain) were 
seen less frequently than pulmonary symptoms in patients with a definite 
diagnosis of Goodpasture's syndrome. Gross hematuria was reported by 10 
patients (20%), edema in 5 (10%), and flank pain in one (2%). Renal symp¬ 
toms co-existed with pulmonary symptoms in six patients. Renal symptoms 
existed without pulmonary symptoms in five patients. 
General symptoms such as fatigue, weakness, and malaise were reported 
in fourteen cases (28%). Feverishness and/or chills occurred in six cases 
(12%). Dizziness or syncope was reported by four patients (8%), and gastro¬ 
intestinal symptoms including anorexia, nausea, vomiting, hematemesis and 
abdominal pain by nine patients (18%). Sore throat, weight loss, skin rash, 
arthralgia, and myalgia were rarely reported presentations. 
Recent past medical histories of patients with a definite diagnosis of 
Goodpasture's syndrome included an upper respiratory illness in six cases 
and intense exposure to organic solvents in six cases. The etiologic agent 
of upper respiratory illness was not isolated in the six cases and where 
- 5 - 

Table II. 
Presenting symptoms in 50 patients with the definite diagnosis 
of Goodpasture's syndrome and in 110 patients with the presump¬ 
tive diagnosis of Goodpasture's syndrome. 
Presenting symptoms Definite Presumptive 
Hemoptysis 39 (78/) 91 (83/) 
Dyspnea 23 (46/) 66 (60/) 
Cough 15 (30/) 46 (42/) 
Fatigue, malaise or weakness 14 (28/) 53 (48/) 
Gross hematuria 10 (20/) 17 (15/) 
Feverishness and/or chills 6 (12/) 25 (23/) 
Anorexia, nausea and/or vomiting 6 (12/) 17 (15/) 
Edema 5 do/) 7 ( 6/) 
Chest pain 4 ( 8/) 9 ( 8/) 
Syncope or dizziness 4 ( 8/) 1 ( 1/) 
Sore throat 2 ( 4/) 7 ( 8/) 
Flank pain 2 ( 4/) 3 ( 3Z) 
Abdominal pain 2 ( 4/) 2 ( 2/) 
Arthralgia 2 ( 4/) i ( iZ) 
Myalgia 2 ( 4/) o ( oZ) 
Weight loss 1 ( 2/) 8 ( 7Z) 
Hematemesis 1 ( 2/) i ( IZ) 
Skin rash 1 ( 2/) 0 ( 0/) 
Nasal discharge 0 ( 0/) 8 ( 7/) 
Polyuria or nocturia 0 ( 0/) 4 ( 4/) 
Dysuria 0 ( 0/) 1 ( IZ) 
Diarrhea 0 ( 0/) 1 ( 1/) 

serologic studies for the presence of streptococcal infection were performed 
they were negative in 11 of 12 cases. The patients with histories of 
exposure to organic solvents had occupations or hobbies which involved in¬ 
halation of the fumes of solvents such as paint stripper, gasoline, and 
varnish remover over a period of many months prior to the onset of their 
illness. 
In patients with presumptive diagnoses of Goodpasture's syndromes 
presenting symptoms occurred at a similar frequency as in those with the 
definite diagnosis of Goodpasture's syndrome (Table II). 
Presenting signs. (Table III) Description of the initial physical 
examination was available in 33 of the 53 patients with a definite diagnosis 
of Goodpasture's syndrome. The two most common signs were pallor which was 
seen in 16 patients (48%) and rales in 12 patients (36%). Of the twenty- 
five patients who had hemoptysis and whose case reports included the initial 
physical examination, rales were heard in only eleven (44%). Edema, hyper¬ 
tension, and retinal hemorrhages were observed 12%, 18%, and 6% of patients 
respectively. Fever was reported in six of the thirty-three patients. 
Hepatomegaly, splenomegaly, lymphadenopathy, cyanosis, clubbing, and costo¬ 
vertebral angle tenderness were uncommon findings. The presenting features 
of the clinical examination were similar in patients with a presumptive 
diagnosis of Goodpasture's syndrome. 
Initial laboratory results (Table IV). Chest X-ray examination was 
performed in forty-three patients with a definite diagnosis of Goodpasture's 
syndrome. Infiltrates were observed in 35 patients (81%). Twenty-seven 
- 7 - 
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Table III. 
Presenting signs in 33 patients with a definite diagnosis of 
Goodpasture's syndrome and 95 patients with a presumptive diagnosis 




Rales 12 (36%) ^3 (4556) 










Edema 4 (1255) 15 (16%) 
Heart murmur 4 
CM
 11 (12%) 
Fundus abnormalities (retinal hemorrhage) 2 ! ( 6%) 4 ( 4%) 
Hepatomegaly 1 ( 3%) 2 ( 2%) 
Cyanosis 1 ( 3%) 0 ( 0%) 
Clubbing 1 ( 3%) 0 ( 0%) 
Lyrnphadenopathy 1 ( 3%) 0 ( of) 
Splenomegaly 0 ( 0%) 2 ( 2%) 
Costovertebral angle tenderness 0 ( 0%) 2 ( 2%) 
Swelling and tenderness of calf 0 ( Of.) 1 ( 1%) 

Table IV, 
Initial laboratory findings in patients with definite and 
presumptive diagnoses of Goodpasture's syndrome. 
Study Definite Presumpt 
Number % Number 
Chest X-ray 
Infiltrates 35 81 79 
No infiltrates 8 19 17 
Hemoglobin concentration or 
or hematocrit 
Hgb £ 10 g/dl or 
Hct < 30 vol% 
32 74 82 
Hgb >10 g/dl or 
11 26 22 
Hct > 30 vol°/o 
Serum iron to iron binding 
capacity ratio 
Less than 0.16 8 80 8 
Greater than or equal to 
0.16 
2 20 1 
Urinary findings 
Total number-'of urinalyses 38 100 
>5 rbcs/hpf 27 71 74 
rbc casts 9 24 11 
proteinuria 27 71 81 
normal urinalysis 6 16 12 
Renal function 
Normal serum creatinine 
13 32 31 or BUN 
Serum creatinine = 1.6-5 
■°16 39 25 or BUN = 26-70 mg/dl 
Serum creatinine = 5*1~9 
or BUN = 71-119 mg/dl 
.9 5 12 12 
Serum creatinine 210 mg/dl „ 
17 15 or BUN >120 mg/dl ( 
Hypocomplementemia 
Total ’number studied ■'■8 1 
Hypocomplementemic M 12 0 
Anti-streptolysin titers 
Total number studied 12 25 
Positive 1 8 2 
Antinuclear antibodies 
Total number studied 9 3 
Positive 0 0 0 

out of thirty-two patients with hemoptysis who had a chest X-ray had 
demonstrable infiltrates. All four patients who presented with dyspnea 
and/or cough but without hemoptysis had abnormal opacifications on the 
chest roentgenogram. Three patients who lacked pulmonary signs or symptoms 
had abnormal chest X-rays. Similar results were observed in the ninety- 
six patients with a presumptive diagnosis of Goodpasture's syndrome who 
had chest X-ray examinations. 
Moderate to severe anemia (hemoglobin concentration <_ 10 g/dl or hemato¬ 
crit £ 30 volumes%) was observed at the time of presentation in thiry-two 
patients (74%) with a definite diagnosis of Goodpasture's syndrome. The 
erythrocyte morphology was most often described as hypochromic microcytic 
and in eight out of ten patients in whom the iron to iron binding capacity 
ratio was determined the ratio was less than 0.15 suggesting iron deficiency. 
Twenty-three out of twenty-nine patients (79%) who presented with hemoptysis 
and had hemoglobin and/or hematocrit measurements were found to have moderate 
to severe anemia. Three out of four patients with dyspnea and/or cough but 
without overt hemoptysis had moderate to severe anemia. Three out of seven 
patients with pulmonary symptoms had hemoglobin concentrations of less than 
10 g/dl. Similar results were observed in patients with a presumptive 
diagnosis of Goodpasture's syndrome with 82 out of 104 (79%) having moderate 
to severe anemia at the time of presentation. 
Urinalysis was performed at the time of presentation in 38 patients 
with definite Goodpasture's syndrome. Twenty-seven (71%) had hematuria but 
only nine (24%) had erythrocyte casts. Twenty-seven patients (71%) had pro¬ 
teinuria. Of the six patients who presented with gross hematuria and had 
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urinalysis results reported all six had proteinuria, but only one was 
reported to have erythrocyte casts. Thirty-three patients who suffered 
from hemoptysis, dyspnea, or cough had urine examinations at the time of 
presentation. Twenty-seven (82%) had an abnormal urinalysis (hematuria, 22; 
proteinuria, 21, rbc casts, 7). Urine examination was performed in 100 
patients with presumptive Goodpasture's syndrome and was normal in twelve, 
all of who presented with pulmonary symptoms. Hematuria, proteinuria, and 
erythrocyte casts were noted in 74%, 81%, and 11%, respectively. 
Renal function on admission was assessed in 41 patients with definite 
Goodpasture's syndrome. Thirteen of these patients had a normal serum 
creatinine (<L5 mg/dl) or urea nitrogen (<25 mg/dl), 16 had creatinine 
concentration between 1.5 and 5 mg/dl (or BUN = 26 to 70 mg/dl), 5 had 
creatinine concentrations between 5 and 10 mg/dl (or BUN = 71 to 119 mg/dl), 
and 7 had a serum creatinine concentration greater than or equal to 10 mg/dl 
(or BUN _> 120 mg/dl). 
In general the presence of an abnormal urinalysis (>5 red blood cells/ 
hpf, red blood cell casts, >1+ proteinuria) was often associated with the 
presence of renal impairment. Eighteen out of twenty-seven patients who 
had abnormal urinalyses had serum creatinine conctrations of greater than 
1.5 mg/dl (or BUN >25 mg/dl). In contrast, none of the four patients with 
a normal urine sediment had elevated serum creatinine or blood urea nitrogen 
concentrations. 
Data on renal function at the time of initial admission were available 
in eighty-three patients with a presumptive diagnosis of Goodpasture's 
11 - 

syndrome. Thirty-one of the 83 (37%) had normal function, 25 (30%) had 
serum creatinine concentrations = 1.5 to 5.0 mg/dl (or BUN = 25 to 70 mg/dl), 
12 (15%) had creatinine level = 5.1 to 9.9 mg/dl, (or BUN = 71 to 119 mg/dl), 
15 (18%) had a serum creatinine concentration of greater than 10 mg/dl or a 
BUN of greater than 120 mg/dl. 
Serum complement was reduced in one out of eight patients with a 
definite diagnosis of Goodpasture's syndrome. Serologic studies for 
evidence of streptococcal infection were performed in twelve patients with 
definite and on twenty-five patients with presumptive Goodpasture's syndrome. 
Only one patient with definite Goodpasture's syndrome and two patients with 
the presumptive diagnosis had elevated titers. In patients in whom circu¬ 
lating antinuclear antibodies were sought, the determinations were negative 
in eight patients with the definite diagnosis and in three patients with 
the presumptive diagnosis of Goodpasture's syndrome. 
Cl ini cal course. Pulmonary abnormalities were the lone presenting 
features in nineteen patients of whom seven had a definite diagnosis of 
Goodpasture's syndrome and twelve had a presumed diagnosis. Four of the 
seven definite Goodpasture's syndrome developed abnormalities in urinalysis 
of renal function within a month after presentation. Renal function and 
urinalysis remained normal in the remaining three patients until 4.5 months, 
1.5 years, and seven years after initial presentation with pulmonary symp¬ 
toms. Five of the twelve patients with presumptive Goodpasture's syndrome 
were discovered to have diminished renal function and/or abnormal urinalyses 
within a month after presentation while the other seven patients were found 
to have abnormal renal studies within five months. 
- 12 - 

Ten patients presented with hematuria or impaired renal function in 
the absence of pulmonary hemorrhage. Four of these patients had a definite 
diagnosis of Goodpasture's syndrome while six had a presumptive diagnosis. 
The four patients with definite Goodpasture's syndrome developed hemoptysis 
one, three, four, and five weeks after initial admission. The six patients 
with the presumptive disease demonstrated pulmonary symptoms at two days, 
one week, three weeks, three months, four months, and two years after 
initial presentation. 
Twenty-six patients (49%) with a definite diagnosis of Goodpasture's 
syndrome and fifty-three (48%) with a presumptive diagnosis who did not 
initially present renal failure developed end-stage renal failure. The pro¬ 
gression of renal disease in patients with definite Goodpasture's syndrome 
was usually quite rapid with a median interval from admission to a serum 
creatinine exceeding 10 mg/dl of five weeks (range 2 days to 11 years). 
The ultimate progression of the renal disease bore little relationship to 
the severity of hematuria or proteinuria at the time of initial admission. 
Yet the ultimate progression of the renal disease to end-stage renal failure 
did appear related to the degree of renal function impairment at the time of 
clinical presentation (Table V). Eighty percent of the cases with definite 
Goodpasture's syndrome and 75 percent with the presumptive diagnosis who had 
serum creatinine concentrations between 5 and 10 mg/dl or BUN between 70 and 
120 mg/dl at onset went on to develop end-stage renal failure resulting in 
either death or long-term commitment to dialysis. Patients who had serum 
creatinine concentrations of less than 5.1 mg/dl (or BUN less than 71 mg/dl) 
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went on to develop renal failure. There was no difference in the renal 
outcome between patients with normal renal function on admission and those 
with only moderately impaired renal function. It is of note that only three 
of the thirty-three patients with definite Goodpasture's syndrome who had 
serum creatinine concentrations exceeding 10 mg/dl recovered enough renal 
function to maintain life without dialysis. 
Renal biopsies were obtained in 41 patients with a definite diagnosis 
of Goodpasture's syndrome (Table VI). Seventeen patients had diffuse 
(majority of glomeruli involved) extracapillary proliferative changes or 
diffuse glomerular sclerosis, and eleven of these seventeen patients had or 
progressed to end-stage renal failure. Seven patients had focal prolifera¬ 
tive lesions or mild diffuse mesangial changes, and only two of this group 
developed renal failure. Five out of six patients whose biopsies revealed 
areas of necrosis and diffuse proliferative changes progressed to end-stage 
renal insufficiency. Eleven biopsies were difficult to categorize because 
of inadequate description of light microscopic morphology although immuno- 
fluorescent studies were consistent with Goodpasture's syndrome. 
Twenty-three of 53 patients with definite Goodpasture's syndrome were 
reported to have died (Table VII). In twelve, death occurred secondary to 
massive pulmonary hemorrhage. Four of the twelve died within one month of 
admission, seven died between two and six months after presentation, and one 
died after an unusually long course of eleven years. There was no apparent 
correlation between renal function at the time of initial presentation and 
the eventual development of fatal pulmonary hemorrhage (Table VIII). 




Summary of renal histology of biopsy specimens obtained from 
4l patients with the definite diagnosis of Goodpasture's syndrome 
and the relationship of renal histology to the development of 
renal failure. 
Glomerular histology 
Focal proliferative or 
mild mesangial changes 
Diffuse proliferative or 
fibrotic changes 
Total number Number with end 
of patients stage renal 
failure ($S) 
7 2 (29?$) 
17 11 (65$) 
Areas of necrosis with diffuse 




Causes of Death in Patients with Goodpsture's Syndrome 
Definite Diagnosis Number Percentage 
Pulmonary hemorrhage 12 52 
Sepsis (Gram negative) 6 26 
Renal failure 2 9 
Viral influenza 1 4 
Aspergillosis, systemic 1 4 
Unknown 1 4 
Total 23 
Presumptive Diagnosis Number Percentage 
Renal failure 35 39 
Pulmonary hemorrhage 31 34 
Pulmonary hemorrhage and 
renal failure 13 
14 
Sepsis (Gram negative) 2 2 
Congestive heart failure 2 2 
Cerebral hemorrhage 2 2 
Epileptic seizure 1 1 




The development of fatal pulmonary hemorrhage as related to 
renal function at initial presentation in patients with the 
definite diagnosis of Goodpasture's syndrome. = serum 
creatinine concentration; BUN = blood urea nitrogen concen¬ 
tration . 
Renal function Total 
scr 11*5 mg/dl or 
BUN < 25 mg/dl 
Scr = 1,6 ” 5-0 mg/dl or 
BUN =26-70 mg/dl 
Scr = 5-1 - 9-9 mg/dl or 
BUN = 71 - 119 mg/dl 
S =10 mg/dl or greater 
cr 
BUN = 120 mg/dl or greater 
No initial or BUN reported 
number Number dying from 
pulmonary hemorrhage 
13 2 (1570 
16 5 (3170 
5 1 (20%) 
7 2 (29%) 
12 2 (17%) 
- 
Nevertheless, of the thirty-five patients who eventually developed end-stage 
renal failure, eleven died of pulmonary hemorrhage (Table IX). In contrast, 
only one of eighteen patients who maintained adequate renal function to 
sustain life died of pulmonary hemorrhage. In six patients the cause of 
death was attributable to gram negative bacterial sepsis. Five of these six 
patients received steroids and/or immunosuppressive agents at the time of 
onset of the signs of sepsis. In only two cases was the cause of death di¬ 
rectly attributable to renal failure. No discernable correlation was ob¬ 
served between the degree of renal insufficiency on initial admission and 
eventual progression to death from all causes (Table X). 
Ninety of the 110 patients (82%) in the presumptive Goodpasture's syn¬ 
drome group were reported to have died (Table VII), A striking difference 
in the cause of death between this group and the definite Goodpasture's 
syndrome was observed. Whereas death secondary to end-stage renal failure 
occurred in only two out of the 23 patients with a definite diagnosis of 
Goodpasture's syndrome, renal failure accounted for 47 out of 90 deaths in 
the group with presumed Goodpasture's syndrome. Causes of death not observed 
in the group with definite Goodpasture's syndrome included congestive heart 
failure (2 patients), cerebral hemorrhage (2 patients), and epileptic 
zeizure (1 patient). 
Thirty of the 53 patients with definite Goodpasture's syndrome were alive 
at the time of publication of their case reports. Twenty-three of these 30 
patients had follow-up of greater than six months after clinical presenta¬ 
tion. Of these twenty-three patients eight were on chronic hemodialysis and 
- 19 - 

Table IX. 
The development of fatal pulmonary hemorrhage 
development of end-stage renal failure in pat 
definite diagnosis of Goodpasture’s syndrome. 
Total number 
Renal failure during ^ 
course of illness 
as related to the 
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two had functioning renal transplants. Six were clinically well with mild 
diminution of renal function and seven were described as alive and in good 
health. Ultimate survival was closely related to changes observed on renal 
biopsy (Table XI). Twenty of the 110 patients with a presumptive diagnosis 
of Goodpasture's syndrome survived. Two of these 20 patients had received 
functioning renal transplants, one was on chronic hemodialysis, and seven¬ 
teen were described as having no or moderate abnormalities in renal function. 
Therapy. One of the most important aspects in the therapy of 
Goodpasture's syndrome has been the use of dialysis in the treatment of 
renal failure (fig. I). Of 107 patients with a definite or presumptive 
diagnosis of Goodpasture's syndrome who developed renal faiIure during the 
course of illness, 63 patients received either peritoneal dialysis or 
hemodialysis. Of the patients who did not receive dialysis, only seven 
percent survived in contrast to 27% of tfie dialysed patients. 
In addition to supportive treatment with dialysis, a number of 
therapeutic regimens have been employed in Goodpasture's syndrome. These 
have included 1) corticosteroids (hydrocortisone, methyl prednisolone, 
prednisone, and dexamethasone) most frequently given at a dose equivalent 
to 60 mg of prednisone per day over several weeks with tapering to a main¬ 
tenance dose after symptoms subsided, 2) immunosuppressive agents (azathio- 
prine, cyclophosphamide, nitrogen mustard, and mercaptopurine) with azathio- 
prine the most commonly used agent, 3) nephrectomy (with or without 
splenectomy), and 4) plasmapheresis combined with immunosuppressive agents 
with or without steroids. 
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Table XI. 
Survival in patients with a definite diagnosis of Goodpasture's 
syndrome as related to histology of renal biopsy specimens. 
Glomerular histology Total number Greater than 6 months 
survival with minor 
or no decrease in 
renal function 
Focal proliferative or 
mild mesangial changes 
7 6 (86#) 
Diffuse proliferative (extra- 
capillary) or diffuse fibro- 
tic changes 
19 1 ( 5#) 
Unclassified histology 13 7 (5W 

Figure 1. 
Effect of dialysis on patient survival in Goodpasture's syndrome. 
Renal failure (106) 

The survival of patients with a definite or presumptive diagnosis 
of Goodpasture's syndrome as related to treatment modality is summarized in 
Table XII. The survival of patients treated with steroids alone (18%) was 
similar to patients treated with supportive therapy (11%). The survival 
of patients treated with immunosuppressive agents (52%), nephrectomy (73%), 
or plasmapheresis (80%) was higher than either steroids or supportive 
therapy. One patient received anti coagulation with supportive therapy 
and survived. 
An important factor contributing to the differences in survival between 
groups was the use of dialysis. Whereas all patients treated by nephrectomy, 
and all patients who needed dialysis who were treated by plasmapheresis 
received dialysis, 91 percent of patients treated by immunosuppressive 
agents who needed dialysis received dialysis, 53 percent of those patients 
treated with steroids received dialysis, and 29 percent of those treated 
with supportive therapy only were dialysed. 
The development of renal failure also differed between the treatment 
groups (Table XIII). While 59 percent of patients who received supportive 
therapy and 68 percent of steroid-treated patients eventually developed 
renal insufficiency, only 17 percent of patients treated with plasmapheresis 
and 52 percent of patients who received immunosuppressive therapy developed 
renal insufficiency. 
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The development of renal failure as related to therapy in 
patients with a definite or presumptive diagnosis of Good¬ 
pasture's syndrome. 
Therapy Total number Number developin 
renal failure 
Supportive therapy 44 26 (59$) 
Steroids 37 25 (68$) 
Immunosuppression 21 10 (48$) 
Plasmapheresis & 1 (1?$) 
- 
DISCUSSION 
Patients with a definite diagnosis of Goodpasture's syndrome had a 
similar clinical presentation to those with a presumptive diagnosis, sug¬ 
gesting that most of the cases with a presumptive diagnosis were indeed 
correctly diagnosed as having Goodpasture's syndrome. Hemoptysis and rales 
with infiltrates on chest roentgenogram, iron deficiency anemia, and an ab¬ 
normal urinalysis with diminished renal function were the major presenting 
features. Presentation with either renal manifestations (6%) or pulmonary 
manifestations (12%) alone was uncommon. 
Direct immunofluorescent staining of renal tissue was performed on 
biopsy or autopsy material in all patients included in the definite 
Goodpasture's syndrome group. The staining was considered positive for the 
demonstration of anti-GBM antibodies if a strong, smooth, linear distribution 
of immunofluorescence was observed. Although positive direct staining of 
the glomerular basement membrane has occasionally been described in patients 
with systemic lupus erythematosis (96) and diabetic glomerulopathy (97, 98), 
these conditions were easily excluded by the clinical history, laboratory 
studies, and renal histology. 
Techniques used to measure circulating anti-GBM antibodies in the 
present case studies included radioimmunoassay, hemagglutination, indirect 
immunofluorescent, and gel immunoprecipitation studies (.99, 100). These 
assays for the detection of circulating anti-GBM antibodies were not quite 
as sensitive as direct immunofluorescent studies performed on renal tissue. 
Of the twenty-seven patients who were tested for circulating anti-GBM 
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antibodies and in whom direct immunofluorescent studies were also performed 
on renal tissue, three had no measurable circulating anti-GBM antibodies. 
If the diagnosis of Goodpasture's syndrome is being entertained and tests 
for circulating anti-GBM antibodies are negative, a renal biopsy with direct 
immunofluorescent staining should be performed. Lung tissue was examined 
for the presence of linear staining of the alveolar capillary basement 
membrane in thirteen patients (three biopsy and ten post mortem specimens). 
Only eight specimens (two biopsy, six post mortem) revealed positive linear 
immunofluorescent staining. All thirteen patients had positive linear 
staining on renal biopsy or autopsy specimens. These results suggest 
that lung biopsy is a less reliable method of establishing the diagnosis of 
Goodpasture's syndrome although a large number of cases have not been studied. 
Nevertheless, in circumstances in which other primary pulmonary processes 
(i.e., infection, tumor, etc.) are being considered in the differential 
diagnosis along with Goodpasture's syndrome, a lung biopsy may be the procedure 
of choice. 
The renal biopsy may also provide useful information concerning the 
eventual development of end-stage renal failure and death. While only 29 
percent of patients with focal proliferative or mild mesangial changes went 
on to end-stage renal insufficiency, 70 percent of patients with diffuse 
crescentic proliferative changes eventually developed chronic renal failure. 
Five out of six patients with diffuse proliferative lesions and necrosis 
developed renal failure. 
Survival also correlated closely with renal histology. Eighty-six 
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percent of patients with focal or mild mesangial lesions were living at the 
time their cases were reported. This was in contrast to only five precent 
of patients with diffuse proliferative lesions. 
The degree of impairment of renal function on admission also bore a 
close relationship to the development of end-stage renal failure and eventual 
death. Whereas 64 percent (29/45) of patients with normal renal function on 
admission progressed to renal insufficiency, 90 percent (36/40) of patients 
with a serum creatinine concentration greater than 70 mg/dl developed end- 
stage renal failure. Mortality was higher in patients with advanced renal 
failure on admission (77%) compared with those with normal renal function 
(59%) if one combined the data from the definite and presumed Goodpasture's 
syndrome groups. Another interesting relationship was that between renal 
failure and pulmonary hemorrhage. Although there was no correlation between 
the development of fatal pulmonary hemorrhage and renal function on admis¬ 
sion (Table VIII),the development of renal failure was associated with a 
striking increase in fatal pulmonary hemorrhage (Table IX). Only one out of 
18 (6%) patients without renal failure succumbed to pulmonary hemorrhage 
while 11 out of 35 (31%) patients with renal failure died of pulmonary 
hemorrhage. Although nephrectomy has been advocated as a life-saving 
measure for massive pulmonary hemorrhage, two of the 15 patients in whom 
nephrectomy was performed eventually died from pulmonary hemorrhage. 
The prognosis as well as the cause of death in patients with 
Goodpasture's syndrome has changed considerably over the last decade. The 
majority of cases with a presumptive diagnosis of Goodpasture's syndrome was 
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reported before 1965 at a time when immunofluorescent techniques for the 
determination of anti-GBM antibodies were not readily available. In this 
group 90 of 100 (82%) died and the leading cause of death was renal failure 
(Table VII). In contrast, only 23 out of 53 (43%) with a definite diagnosis 
of Goodpasture's syndrome died and renal failure accounted for only 9 percent 
of this group (Table VII). A major difference influencing the eventual out¬ 
come and cause of death between these groups of patients appeared to be the 
availability of dialysis. While end-stage renal failure occurred with 
equal frequency in both groups only 39 percent of patients with a presump¬ 
tive diagnosis who needed dialysis actually received dialysis compared to 
94 percent with a definite diagnosis. As can be seen in figure 1, 27 percent 
of patients treated with dialysis survived compared to only 7 percent who 
were not dialyzed. 
Because of the infrequent occurrence of Goodpasture^s syndrome and its 
poor prognosis, controlled prospective studies examining different modalities 
of therapy have not been feasible. Therefore, caution must be exercised in 
interpreting the results of therapeutic intervention in this disease. 
Steroids in conventional doses (40 to 80 mg of prednisone per day or its 
equivalent) appeared to have little benefit over supportive therapy alone. 
High doses of steroids (e.g., methyl prednisolone 1 gram every 8 hours) may 
be more effective although only a few patients have been reported who have 
received such therapy (20). Immunosuppressive therapy in combination with 
steroids was associated with a higher survival rate (52%) than in the group 
treated with steroids alone (18%) (Table XIII). However, dialysis was em¬ 
ployed with greater frequency in patients treated with immunosuppressive 
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agents (91%) than in patients treated with steroids alone (53%). Whether 
the increased survival was attributable to treatment per se or to the 
greater availability of dialysis cannot be determined. It should be noted, 
however, that 68 percent of the steroid treated group progressed to renal 
insufficiency compared to 48 percent of patients treated with immunosup¬ 
pressive agents. 
The best results were obtained in patients treated with bilateral 
nephrectomy or plasmapheresis, approximately three-quarters of the patients 
surviving in both groups. Interpretation of the results obtained with 
nephrectomy is made difficult by the small numbers of patients receiving 
nephrectomy and by the decisions surrounding the application of this mode 
of therapy in the individual patient. At least two factors must be present 
if nephrectomy is to be performed; 1) the patient must be stable enough to 
endure the operation and 2) chronic dialysis facilities must be available to 
the patient. The most efficacious therapy would be one that not only pre¬ 
vents pulmonary hemorrhage but also prevents the development of renal 
failure. Obviously, nephrectomy does not achieve the latter goal and whether 
it prevents pulmonary hemorrhage must be questioned since at least two 
patients have been reported who died of massive pulmonary hemorrhage after 
nephrectomy. 
Most recently, plasmapheresis has been advocated in the treatment of 
Goodpasture's syndrome (21- 23, 38). Of the ten with this modality, eight 
have survived and only one out of six patients progressed from normal or 
moderately diminished renal function to renal failure. The rationale be¬ 
hind the use of plasmapheresis is to remove directly those circulating 
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antibodies which are responsible for the renal and pulmonary damage. 
Although the results to date seem encouraging and plasmapheresis seems to 
be a relatively safe procedure, it should be noted that all patients treated 
with plasmapheresis have also received steroids and/or immunosuppressive 
agents. In addition, the correlation between circulating anti-GBM antibodies 
and the improvement in pulmonary hemorrhage and renal function has been 
poor (23). If plasmapheresis proves to be beneficial, it remains to be 
determined whether its efficacy is based upon removal of circulating anti- 
GBM antibodies or upon removal of other mediators of the host response. 
In summary, maintenance dialysis for those patients who develop renal 
failure appears to be an important factor for the improved outlook in pa¬ 
tients with Goodpasture's syndrome. Conventional doses of steroids seem to 
be without effect on either long-term survival or preservation of renal 
function. Although the outcome in patients treated with immunosuppressive 
and/or cytotoxic agents is slightly better than those treated with supportive 
therapy or steroids alone, the efficacy of these agents remains to be proven. 
The results of nephrectomy are similar to those obtained with plasmapheresis. 
Since nephrectomy can be expected to have a significant incidence of morbi¬ 
dity and mortality in this patient population and since nephrectomy auto¬ 
matically commits the patient to life long dialysis, plasmapheresis may be a 
better therapeutic option. It should be clearly understood, however, that 
plasmapheresis is still of unproven benefit at the present time. Because of 
the infrequent occurrence of Goodpasture's syndrome a controlled study 
involving several institutions would be necessary to provide the information 
necessary for determining the efficacy of the various modes of therapy in 
this condition. 




This 51-year old female first presented at Yale-New Haven Hospital with 
a six month history of coughing up bright red blood. She denied feverishness, 
chills, night sweats, and weight loss. Past history included exposure to 
tuberculosis and to irritating fumes at the electrician's shop where she 
worked. She also had been followed at the orthopedic clinic because of 
arthralgias due to osteoarthropathy. On admission the physical examination 
was unremarkable except for swelling and tenderness along the course of the 
greater saphenous vein. Her hematocrit was 28 vol%, hemoglobin concentra¬ 
tion 8.7 g%, WBC 9800 with normal differential. BUN was 12 mg/dl, serum 
electrolytes were normal, serum iron 13 mg/dl, serum iron binding capacity 
373 yg/dl, total protein 6.8 g/dl , albumin 3.7 g/dl. Prothrombin and partial 
thromboplastin time were within normal limits. Liver function tests were 
normal. EKG was also within normal limits. Arterial blood p02 was 84 torr 
and pCOg 36 torr. Chest x-ray was unremarkable as was pulmonary angiography 
and bronchography. Bronchoscopy revealed blood in the right middle lobe and 
right 1 ower lobe bronchial orifices. Sputum cultures and cytology were 
negative. PPD was non-reactive. One urinalysis during her first week of 
hospitalization revealed 2 to 10 rbc's/hpf and 1+ proteinuria. Four others 
were normal or contaminated. The patient's superficial thrombophlebitis 
resolved and her hemoptysis gradually decreased. She was discharged on 
ferrous sulfate (300 mg three times a day orally). 
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She continued to have intermittent periods of production of blood- 
tinged sputum and developed parasternal chest discomfort occurring at rest and 
upon exertion and was closely followed in the chest clinic until six months 
after her initial admission when she was re-admitted because of continued 
hemoptysis, chest pain, and weakness. Urinalysis revealed 3+ proteinuria 
and 20 rbs/hpf. BUN was 28 mg/dl and serum creatinine concentration was 
2.5 mg/dl. Chest roentgenogram showed right lower lobe and left lower lobe 
ground glass densities.. An open lung biopsy was performed and showed intra- 
alveolar hemorrhage and scarring. Renal histology of a sample obtained by 
percutaneous biopsy was markedly distorted with many hyalinized glomeruli, 
and marked epithelial proliferation and areas of necrosis in the remaining 
glomeruli. During her admission hemoptysis ceased prior to the onset of 
treatment with prednisone (10 mg daily) and azathioprine (100 mg/day). 
This patient has been followed in renal-metabolism clinic for the past 
11 years over which time she has become hypertensive and has gradually lost 
renal function. At last visit to the clinic, she was feeling well on her 
therapy consisting of azathioprine (100 mg daily), hydrochlorthiazide, 
sodium bicarbonate and amphogel, Her serum creatinine concentration is 
8.5 mg/dl, sodium 140 meq/1, potassium 5.2, chloride 100, bicarbonate 18.3. 
Her calcium was 8.6 mg/dl and phosphorus 7.4. Urinalysis revealed 2+ 
proteinuria, 10-20 rbc's/hpf, and 1-3 wbcs/hpf. 
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Case 2: 
This 51-year-old white male was admitted to Yale-New Haven Hospital 
because of weakness, left flank pain, nausea, vomiting, and diarrhea for 
three weeks. He stated that he was healthy all his life except for hyper¬ 
tension which had been discovered two years before this admission. Three 
weeks orior to admission the patient developed intermittent nausea, vomiting, 
anorexia, diarrhea, and generalized weakness. He also suffered from left 
flank pain which increased with respiration and was associated with nocturia 
but not dysuria. The patient saw his private physician one week prior to 
admission at which time a urinalysis revealed hematuria. The patient was 
instructed to rest in bed and to take anti-emetic medications. At first he 
felt better and even returned to work but three days before admission the 
flank pain and fatigue returned. He denied cough, hemoptysis, skin rashes, 
and sore throat. Family members noticed that the patient had puffy eyes for 
about two weeks. The patient was admitted for further evaluation and 
treatment. 
Physical examination revealed a middle-aged man in no acute distress. 
BP 190/110, pulse rate 92 regular, temperature 99°F, respiratory rate 13. 
He had 1+ periorbital edema. A-V nicking but no hemorrhages or exudates 
were noted on fundoscopic examination. His chest was clear. He had left 
flank tenderness. Laboratory studies: hemoglobin concentration was 10 g/dl, 
hematocrit 32 vo1%, WBC 6,700 (normal differential). Serum glucose was 
75 mg/dl, BUM 60 mg/dl, creatinine 9.5 mg/dl, sodium 140 meq/1, potassium 
6.1, chloride 104, and bicarbonate 18.4. Urinalysis revealed a specific 
gravity of 1.011, 3+ proteinuria, 5-6 wbcs/hpf, and numerous rbcs/hpf. 
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Initial chest x-ray demonstrated a slightly enlarged heart with clear lung 
fields. The patient's serum iron concentration was 55 pa/dl and iron 
binding capacity was 323 yg/dl, A twenty-four hour urine collection and 
protein determination revealed a protein excretion rate of 3.5 g/24 hours. 
Two days after admission the patient developed severe hemoptysis which 
was associated with peri hilar alveolar-type infiltrations on chest x-ray. 
A renal biopsy was performed. Light microscopic examination of the tissue 
showed chronic and active focal necrotizing glomerulonephritis with cres¬ 
cents affecting all glomeruli and some interstitial scarring. He was treated 
with prednisone (40 mg daily) and azathioprine (100 mg daily) as well as with 
peritoneal and hemodialysis. Despite therapy the patient died 18 days after 
admission as a result of acute respiratory insufficiency and hyperkalemia. 
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Case 3: 
This 21-year-old white female, one pack-per-day smoker was admitted to 
a community hospital because of fatigue, malaise, and anorexia beginning 
three weeks prior to admission, gross painless hematuria starting two weeks 
before admission, nausea and vomiting with flank discomfort one week prior 
to admission, and hemoptysis and dyspnea for three days. The patient re¬ 
ported intermittent cough productive of small amounts of blood for 6 months. 
Physical examination at initial presentation was unremarkable. Laboratory 
studies revealed a hemoglobin of 12 g/dl and a hematocrit of 36 vol%. Her 
BUN was 12 mg/dl, serum creatinine 1.1 mg/dl. Antinuclear antibody, ASLO 
titers and studies were all within normal limits. Urinalysis revealed 
numerous red blood cells. Chest roentgenogram showed a diffuse miliary 
infiltrate. An intravenous pyelogram was read as normal. Cystoscopy re¬ 
vealed bleeding from both ureteral orifices. Bronchoscopy showed no 
focal source of bleeding. Within one week after admission she became acutely 
dyspneic and pale and developed diffuse rales on examination. She was sub¬ 
sequently transferred to Yale-New Haven Hospital for further evaluation and 
treatment. 
On admission the patient appeared acutely ill, dyspneic and pale. Her 
pulse was 130, respiratory rate 45, temperature 99°F, and BP 120/50. She 
had diffuse rales and rhonchi and 1+ pretibial edema. Her hemoglobin con¬ 
centration was 4.7 g/dl, hct 14.7 vol%, WBC 9,900 (70 segs, 2 bands, 17 
lymphocytes, 8 monocytes, 3 eosinophils), 140,000 platelets. Urinalysis: 
specific gravity 1.006, pH 6,0, 2+ proteinuria, numerous rbcs/hpf, 6-8 wbcs/ 
hpf. Her BUN was 60 mg/dl, serum creatinine 7.0 mg/dl, sodium 129 meq/1. 
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potassium 5.1, chloride 102, and bicarbonate 16. Serum protein was 4.9 g/dl 
and albumin 2.4 g/dl. ASLO titer was 250. Rheumatoid factor, antinuclear 
antibody, prothrombin time and partial thromboplastin time were within 
normal limits. 
Because of the severity of hemoptysis several transfusions with leuko¬ 
cyte poor blood were required to keep the patient’s hematocrit above 20 
vol%. Peritoneal and hemodialysis were performed beginning the first week 
after admission because of renal insufficiency (serum creatinine exceeding 
10.0 mg/dl). The patient’s course was complicated by peritonitis treated 
with antibiotics, by staphylococcal parotitis, by left retinal artery 
occlusion, and by periods of hypotension and thrombocytopenia. Despite 
treatment with blood and platelet transfusions, prednisone (60 mg daily), 
azathioprine (100 mg daily), antibiotics, and mechanical respiratory assis¬ 
tance, the patient became comatose and died one month after admission. 
At post mortem examination the patient was found to have widespread 
aspergillosis with fungal elements in the central nervous system, lung, 
peritoneal cavity and myocardium. She had multiple gastric ulcers with 
evidence of gastrointestinal hemorrhage, left retinal artery occlusion, 
massive pulmonary hemorrhage with hemosiderosis and diffuse crescentic 
glomerulonephritis with necrosis of capillary tufts and early hyalinization 
of glomeruli'. There was linear deposition of IgG on glomerular and pulmonary 
capillary basement membranes as detected by direct immunofluorescent studies. 
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Case 4: 
This 24-year-old white man was in excellent health until two years prior 
to his admission to this hospital at which time he presented to another 
hospital with cough with hemoptysis (1/2 cup per day), myalgias, and arthral¬ 
gias. He was reported to have had a normal physical examination. Laboratory 
investigations revealed a hemoglobin concentration of 9 g/dl, sedimentation 
rate of 40, a serum iron concentration of 7 yg/dl, an elevated rheumatoid 
factor of 512, and an abnormal chest x-ray revealing bilateral patchy infil¬ 
trates. An open lung biopsy was subsequently performed. Examination of the 
biopsy specimen by light microscopy showed intra-alveolar hemorrhage, 
thickened alveolar septae, and hemosiderin-laden macrophages. The patient 
was started on prednisone (150 mg daily). Hemoptysis, arthralgias, and 
myalgias subsequently terminated and the hemoglobin concentration returned 
to normal levels. 
The patient did well until one year later when he again presented with 
hemoptysis. He also had a nodular lesion on his left elbow. The histology 
of a biopsy specimen of the nodular lesion was thought to be consistent with 
that of a rheumatoid nodule. He did well after re-institution of high dose 
prednisone therapy. 
Six months later the patient again suffered from a recurrence of 
hemoptysis.' He was started on prednisone and azathiprine which resulted in 
subsidence of hemoptysis. 
He was referred to Yale-New Haven Hospital for further evaluation six 
months later. On admission, except for a Cushingoid appearance, the physical 
examination was within normal limits. His hemoglobin level was 11.9 g/dl. 
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hematocrit 34 vol%, WBC 13,800 (85 segs, 2 bands, 8 lymphocytes, 4 monocytes, 
1 metamyelocyte). Urinalysis disclosed a specific gravity of 1.019, 1+ 
proteinuria, 0-1 wbc/hpf, 5-8 rbcs/hpf. Serum creatinine concentration was 
0.9 mg/dl , BUN 25 mg/dl, sodium 139 meq/1 , potassium 5.0, chloride 104, and 
bicarbonate 26. Creatinine clearance was 117 ml/min. Prothrombin and 
partial thromboplastin times were normal. Serum complement (C^) level was 
normal. Rheumatoid factor was negative. Chest x-ray showed blunting of 
the right costophrenic angle with a slight increase in density of the right 
lower lobe. IVP was within normal limits. Sputum smears and cultures were 
negative for acid fast organisms. Light microscopy of percutaneous renal 
biopsy specimen revealed twenty-five glomeruli showing various degrees of 
hypercellularity, focal segmental necrosis and active epithelial crescent 
formation in over half of the glomeruli. Electronmicroscopy showed some 
collapse of the basement membrane but no electron dense deposits. Direct 
immunofluorescent staining showed a linear pattern for IgG within the glo¬ 
meruli and granular deposits of IgG within the mesangial matrix. The patient 
was discharged and treated with prednisone (100 mg daily). 
One month after discharge he developed a skin rash which was biopsied 
and revealed a leukocytoclastic angiitis. The rash resolved shortly after 
treatment with methotrexate (50 mg/week) was instituted. Since that time 
until the present (over 2 1/2 years after initial presentation, he has been 
asymptomatic but continues to have 2+ proteinuria and 3-5 rbcs/hpf. 
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Case 5: 
This 47-year-old white male was admitted to a community hospital 
because of left upper quadrant abdominal pain, guaiac positive stools and 
abnormal chest x-ray. Ten days prior to admission he began to experience 
early satiety. Three days prior to admission he developed left upper qua¬ 
drant pain which was accentuated by deep inspiration. He denied hemoptysis, 
melena, hematemesis, and hematochezia. Past medical history was significant 
for peptic ulcer disease nine years before admission. 
Physical examination showed a pale, white middle-aged man in no acute 
distress. Temperature was 99°F, blood pressure 110/70, pulse 88, respiratory 
rate 12 per minute. The remainder of the physical examination was unre¬ 
vealing except for 2+ guaiac positive stools. 
Laboratory studies: Hemoglobin concentration was 8.0 g/dl, hematocrit 
27 vol%, WBC 8,100 (68 polys, 1 band, 3 eosinophils, 25 lymphs, 2 atypical 
lymphs, and 1-2 nucleated rbcs/100 wbcs). Platelets appeared adequate in 
number. Reticulocyte count was 10.8%. Urinalysis revealed a specific 
gravity of 1.024, pH 6.0, protein 30 mg/dl, 10-20 rbcs/hpf, no casts. BUN 
was 10 mg/dl, serum creatinine 1.6 mg/dl, sodium 137 meq/1, potassium 4.0, 
chloride 102, bicarbonate 25. Serum iron concentration was 40 yg/dl and a 
serum iron binding capacity 364 yg/dl. Sputum showed hemosiderin-filled 
macrophages.- ANA, LE prep, and AS0T studies were within normal limits. 
Chest x-ray showed extensive alveolar infiltrates in the right lower lobe 
and right middle lobe. Pulmonary function tests were consistent with moderate 
restrictive disease with reduced maximum voluntary ventilation. Arterial 
blood gas determinations revealed a pH of 7.48, pC02 of 33 mmHg, and p02 of 
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66 mmllg. Upper GI barium studies demonstrated a deformity of the duodenal 
bulb but no ulcer. IVP was within normal limits. A twenty-four hour urine 
collection revealed a protein excretion rate of 2 g/24 hours. 
Over the next two weeks, the patient experienced progressive deteriora¬ 
tion of renal function with BUN concentrations going to 77 mg/dl and creati¬ 
nine concentrations to 5.6 mg/dl. In addition he experienced two episodes 
of hemoptysis. He was started on prednisone 80 mg daily and was then trans¬ 
ferred to Yale-New Haven Hospital for further evaluation and consideration 
of additional therapy. 
Physical examination at Yale-New Haven Hospital revealed an afebrile 
white male with mild respiratory distress. Respiratory rate was 25 per 
minute, blood pressure 130/80, and pulse 72. He had diffuse rales bila¬ 
terally. His admission BUN concentration was 92 mg/dl and creatinine con¬ 
centration was 10.0 mg/dl. Over the next two weeks the serum creatinine 
concentration increased to 13 mg/dl. He underwent peritoneal dialysis and 
was begun on azathioprine (75 mg daily) along with prednisone (60 mg daily). 
A renal biopsy was performed and light microscopic examination of the speci¬ 
men revealed severe necrotizing and crescentic glomerulonephritis. Direct 
immunofluorescent studies demonstrated linear deposition of IgM along the 
glomerular basement membrane. Three days after peritoneal dialysis was 
initiated the patient had a spontaneous diuresis. Shortly thereafter (3 weeks 
after transfer) he was discharged on prednisone (60 mg daily), azathioprine 
(75 mg daily) and antacids. 
Over the next two years he was followed in the renal-metabolism clinic. 
His prednisone was gradually tapered over a period of eighteen months. He 
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was maintained on azathioprine (100 mg daily) and his antacids. His BUN 
and serum creatinine concentrations fell to 41 and 2.8 mg/dl, respectively. 
Thirty months after the onset of illness the patient was admitted for 
right upper quadrant abdominal pain, leukocytosis, and fever. He was found 
to have a ruptured appendix at operation. He tolerated the procedure well. 
Three years and five months after his initial presentation the patient 
was noted to have gradual deterioration of renal function despite azathio¬ 
prine therapy (100 mg daily). His serum creatinine concentration was 4.1 
mg/dl at that time. A renal biopsy was performed which revealed severe 
interstitial and glomerular fibrosis. A minority of glomeruli were well- 
preserved and others showed persistent proliferative changes. 
Four months later he developed shortness of breath and diminished 
exercise tolerance. His hematocrit v/as found to be 10 vol%. He was trans¬ 
fused and started on digoxin. A good clinical response was observed. 
This patient's final admission occurred three years and eleven months 
after the onset of his illness. He was admitted because of a one day history 
of gross hemoptysis. He was in mild respiratory distress and had rales at 
both bases. His BUN concentration was 143 mg/dl and serum creatinine v/as 
12.5 mg/dl. His hemoglobin concentration was 4.7 g/dl, hematocrit 15 vol%, 
and WBC 8,300 (81 segs, 9 bands, 10 lymphs). Urinalysis demonstrated 3+ 
proteinuria'and numerous red blood cells. Arterial blood gas determinations 
indicated a pH of 7.43, pOg of 46 mmHg and pC02 of 20 mmHq. He experienced 
rapid clinical deterioration with the development of respiratory failure, 
GI bleeding, staphylococcal pneumonia, and Pseudomonas and staphylococcal 
sepsis despite aggressive management with mechanical ventilatory assistance 
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(with positive end-expiratory pressure), intensive antacids, antibiotics, 
methyl prednisolone (250 m3 every six hours), cyclophosphamide (150 mg daily), 
and peritoneal dialysis. The patient died twelve days after admission of 
massive gastrointestinal hemorrhage, sepsis and his underlying disease. 
At autopsy he was found to have pulmonary hemorrhage and hemosiderosis 
with bilateral interstitial and bacterial pneumonias, and pleural effusions. 
Staphylococcus aureus and Pseudomonas aeruginosa were cultured from blood 
and lung tissue. Multiple ulcers in the stomach, duodenum, and colon were 
also found. The kidneys showed bilateral cortical scarring with marked 
hydronephrosis. Microscopic examination of the kidneys revealed diffuse 
interstitial fibrosis, generalized diffuse glomerulosclerosis with mesangial 
thickening and scarring in a segmental distribution in the remaining 
glomeruli. Direct immunofluorescence studies revealed no deposition of 
immunoglobulins along the glomerular basement membrane. The urinary bladder 
was trabeculated and there was a prominent medial lobe of the prostate. 
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